Efmitermant alfa, a locally-acting GDF/activin ligand trap, is under investigation in clinical trial NCT03124459 (Study of ACE-083 in Patients With Charcot-marie-tooth Disease).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.